Cardiac Resynchronization Therapy Devices (CRT)

Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Feature | Cardiac Resynchronization Therapy Devices (CRT) | Valentina Kutyifa M.D., Ph.D.

BIO-LIBRA Study Evaluates Role of Sex and Device Type in Non-ischemic Cardiomyopathy

Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often ...

March 09, 2020

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Feature | EP Lab | Hrishikesh Kadam

The Future of Cardiac Rhythm Management Device Technology

Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing ...

November 11, 2019

FDA Approves Barostim Neo System for Advanced Heart Failure Patients. Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels.

Technology | Heart Failure

FDA Approves Pacemaker-like Device to Treat Heart Failure

August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the ...

August 19, 2019

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | Dave Fornell, Editor

New Technology and Market Challenges Facing Implantable Cardioverter Defibrillators

This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology ...

May 24, 2019

HRS 2019 late breaking trials, late breaking presentations for the biggest news in electrophysiology (EP). #HRS #HRS2019 #HRS19

Feature | HRS | Dave Fornell, Editor

Heart Rhythm Society 2019 Late-Breaking Clinical Trials

May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-breaking study presentations at the 2019 Heart Rhythm ...

May 15, 2019

A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

News | EP Lab

Implantable EP Device Infection Risk Score Unveiled at HRS 2019

May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The ...

May 15, 2019

News | EP Lab

Studies Find Race and Gender Disparities in Implantable Heart Devices

May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, including ...

May 15, 2019

News | Cardiac Resynchronization Therapy Devices (CRT) | Dave Fornell, Editor

His Corrective Pacing Effective as an Initial Strategy for Heart Failure Cardiac Resynchronization

May 15, 2019 — A pilot trial has shown His pacing in cardiac resynchronization therapy (CRT) has been shown to ...

May 15, 2019

News | EP Lab

Survey Shows Big Need for Patient Education on Their Implantable Electrophysiology Devices

May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their ...

May 13, 2019

News | Pacemakers | Dave Fornell, Editor

FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers

May 7, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers ...

May 07, 2019

News | Cardiac Resynchronization Therapy Devices (CRT)

Biotronik Launches Acticor DX and CRT-DX Devices in U.S.

April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and ...

April 29, 2019

News | Cardiac Resynchronization Therapy Devices (CRT)

Biotronik Launches Acticor and Rivacor ICD and CRT-D Devices in Europe

April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest implantable ...

April 18, 2019

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Feature | EP Lab

FDA Issues Safety Alert on Cybersecurity Vulnerabilities of Medtronic ICD, CRT Devices

March 22, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers ...

March 22, 2019

Technology | Cardiac Resynchronization Therapy Devices (CRT)

FDA Approves 3T Acticor and Rivacor Tachycardia Devices from Biotronik

March 15, 2019 – Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor high ...

March 15, 2019

Videos | EP Lab

VIDEO: Use of a Virtual Heart For CRT Lead Placement Optimization

This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help ...

February 27, 2019